https://www.selleckchem.com/products/ms-275.html
The goal of this work is to facilitate GCT molecular basis exploration and translational research.While the majority of patients with advanced testicular germ cell tumors (GCT) achieve complete responses after chemotherapy and if indicated after postchemotherapy resection of residual lesions, about 20% of patients have incomplete responses or show relapses. Moreover, toxicity of chemotherapy is high, and severe adverse chronic effects have been described. Therefore, there is an urgent need for biomarkers that could help to improve tumor
पसंद करना
टिप्पणी
शेयर करना
